Publicacions en col·laboració amb investigadors/es de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (32)

2024

  1. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  2. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  3. Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564

  4. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  5. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Emphysema: the risk of cancer and the impact on cancer care

    ERS Monograph, Vol. 2022, Núm. 98, pp. 105-117

2021

  1. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36

  2. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

  3. Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106

2020

  1. A delphi consensus document on the use of single-inhaler fixed-dose triple therapies in copd patients

    International Journal of COPD, Vol. 15, pp. 1801-1811

  2. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

  3. Protein succination as a potential surrogate biomarker of airway obstruction. The ilervas project

    Respiratory Medicine, Vol. 172

  4. Somatotypes trajectories during adulthood and their association with copd phenotypes

    ERJ Open Research, Vol. 6, Núm. 3, pp. 1-9

2019

  1. 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

    Thorax, Vol. 74, Núm. 4, pp. 371-379

  2. External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study

    COPD: Journal of Chronic Obstructive Pulmonary Disease

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

  2. Temporal transitions in COPD severity stages within the GOLD 2017 classification system

    Respiratory Medicine, Vol. 142, pp. 81-85

  3. The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study

    Respirology, Vol. 23, Núm. 5, pp. 485-491

2017

  1. Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 53, Núm. 10, pp. 574-582